Notably, upon OLE treatment of the K562 AML cell line, we highlighted a negative modulation of five different molecules, all involved in the TRAF2 signaling (i.e., TRAF2, TRAIL R1, IkB epsilon, CD40, and Ikkg/NEMO) [81,82]. The gene discussed is CD40; the disease is acute myeloid leukemia.